Migraine Headaches Study | Central Kentucky Research
AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know. To learn more about AMR’s fully integrated network, click here: amrllc.com.


Migraine Headaches Study

  • August 2, 2018

The purpose of this study is to evaluate the safety and tolerability of chronic intermittent use of an investigational medication for 24 or 52 weeks in patients with migraine headaches.

Duration:  Up to 58 weeks

Number of visits to CKRA:  Up to 13

Compensation:  $75.00 per completed clinic visit

Note:  Qualified participants must be between the ages of 18 and 65 years old, have at least 2 migraine headaches per month, and must not suffer from chronic migraines or any other chronic headache syndrome.  Other criteria also apply.